Archived News & Announcements

Dear ISSDP members, affiliates, and previous members/attendees:

Elections for our new Vice President will take place in October 2025. For this election, we have an open call for nominees globally (not limited to any region). We are now inviting nominations (including self-nominations) for this important role.

The deadline for nominations is October 15, 2025.

The Vice President will assume the role for 1.5 years, moving into the role of President when the current President’s (Caitlin Hughes) term is concluded (end of the 2027 ISSDP Conference, June 2027). The Vice President plays an important leadership role on the Board and hence the position involves a greater time commitment than Board membership. We strongly encourage that interested nominees contact the current President (caitlin.hughes@flinders.edu.au) and/or Vice President (kilmer@rand.org) for details and discussion about the responsibilities of this role.

Nominations should be supported by a proposer and seconder who are both members of ISSDP. The proposer and seconder should ensure that the person nominated is a current ISSDP member (not affiliate) and is willing to serve. Self-nominations, with a proposer and seconder, are also welcome. If you are unsure of your current status, please ask us.

Note, our by-laws state that the President and Vice-President shall represent two different countries. The current President, Caitlin Hughes, represents Australia, therefore the nominee should be from a different country. Each member of the Board is considered to represent the country of their primary institutional affiliation, regardless of country of birth or citizenship. We highly encourage nominees from the Global South, although this is not required.

Please email nomination details to Alissa Greer (committee Chair) Alissa_greer@sfu.ca by Wednesday, October 15. Each nomination should be accompanied by a personal statement (two pages maximum) and a nominee photograph with the details below which will be circulated with the ballot paper. The personal statement should consist of:

• A short biography of the nominee.
• A short comment about their past engagement with the society (e.g. being a current/past board member, attending conferences, contribution to scientific committees, sub-committees etc.).
• A note on the skills they will bring to the Vice President role.
• A comment on why they wish to run for Vice President and outline of what they hope to accomplish in this important role, including contributions to our priority areas of 1) building global south engagement and 2) mentorship of future scholars.

After the closing date for nominations (October 15, 2025), a ballot listing all nominees, their personal statement, and photograph will be circulated via email to ISSDP members for online voting for 10 days (open from October 20-29, 2025). The results will be reported to the Board before November 1 and announced to our members shortly thereafter.

The current ISSDP Board consists of the President (Caitlin Hughes, AU), the outgoing Vice-President (Beau Kilmer, USA) and Trustees: Rebecca Askew, UK; Yatan Pal Singh Balhara, IN; Alissa Greer, CA; Marie Jauffret-Roustide, FR; Gideon Lasco, PH; Bronwyn Myers, AU; Aileen O’Gorman, SCO/UK; Rosalie Liccardo Pacula, USA (immediate past President); Jessica Storbjörk, SW; Liesbeth Vandam, PT. The Founding President (Peter Reuter, USA) is an ex-officio Board member. Lucy Strang (Treasurer) and Elle Wadsworth (Secretary) are Board attendees.

Please contact us if you have any questions.

ISSDP Electoral Committee: Alissa Greer (Chair) (Alissa_greer@sfu.ca), Nicola Singleton (Nicola.Singleton@kcl.ac.uk), Karen Laidler (kjoe@hku.hk), Naomi Zakimi (nzakimi@sfu.ca).

As reported in our ISSDP April newsletter (emailed 04/04/25), our current Vice President Beau Kilmer will step down as VP after our annual conference in Manchester. In his resignation letter Beau explained that it is time to diversify our leadership so that we are truly an international organisation that values expertise and drug policy challenges outside the Anglosphere. By stepping down now Beau makes way for a new Vice President who will have two years to work with and be supported by the current President Caitlin Hughes and the Board before taking on the role of President in 2027.

We now seek nominations to fill the vacancy of the Vice President. We wish particularly to encourage nominees from the global south.

Nominations are due 19 May 2025 (by the end of day in the country of origin).

Nominations should be supported by a proposer and seconder who are both members of ISSDP. The proposer and seconder should ensure that the person nominated is a current ISSDP member (not affiliate) and is willing to serve. Self-nominations, with a proposer and seconder, are welcome also. To find out more details please reach out to below:

Nominations Committee: Aileen O’Gorman (Chair: Aileen.O’Gorman@uws.ac.uk); Simon Lenton; and Nicola Singleton.

Also please reach out to our current ISSDP President and Vice President if you would like to discuss your prospective nomination.

The ISSDP Excellence in Research Award is an annual recognition sponsored by the International Society for the Study of Drug Policy. First conferred in Leuven, Belgium, in 2023, the award aims to recognize a piece of research published in the past 3 years that has made a substantial innovation in how we think about or conduct research in the area of drug policy. Eligible topics include (but are not exclusively limited to)  the methods and data used for conducting drug policy analysis, the theoretical models of or frameworks guiding work on the agents (consumers, suppliers, regulators) or systems (drug markets, health providers, criminal justice system, social services) that influence drug policy, and/or practical understanding of drug policy in the world today.

Award
The awardee/s will receive a formal certificate from the society, a monetary award of at least US $3000, an allowance to cover travel and conference costs, as well as the opportunity to give a 30-minute presentation at the annual ISSDP meeting (For 2025, this will be in Manchester, UK, on June 11 to 13). If the publication has multiple authors, they will have to choose one person to come to the meeting and accept the award

Eligibility criteria

• Any English-language research publication (article, book, or report), published in the past three years, is eligible for consideration. For 2025, the publication must have been published from January 2022 to December 2024.
• For the purposes of the award, “research” should be interpreted broadly and inclusively to refer to original and relevant scholarship in any subfield within the domain of drug policy, broadly construed. The award is open to both quantitative and qualitative research methods.
• The author/s of the nominated publication may or may not be an ISSDP member and will be considered regardless of their institutional affiliation or nationality.

Nominations
Anyone who wishes to nominate a paper for consideration (self-nominations are welcome) should send their nominations to Gideon Lasco (pdlasco@up.edu.ph) by March 31, 2025.

ISSDP will name an awards jury of five members from among its board members and drug policy scholars to evaluate the nominations. The decision of the committee will be relayed via email to the authors of the winning publication by April 15, and announced to the public during the annual ISSDP conference, both on-site and electronically.

Dear ISSDP colleagues,

Members of the International Society for the Study of Drug Policy (ISSDP) are invited to nominate themselves, or other members, for vacancies that have arisen on the ISSDP Board. The vacancies are to replace Kari Lancaster, who is stepping down, and to fill the maximum number of Board members permitted.

ISSDP Board: The role of the ISSDP is to advance education and research on drug policy through publication, dissemination, and engagement. Board members are the Charity Trustees of the Society. Their role is to manage the property and business of the Society. This involves discussions on conferences/seminars, meetings, relations with other associations and the principles/policies of ISSDP. Board meetings are held at least twice a year, in person at the annual conference and thereafter online. In between meetings, business is dealt with by email and though the work of sub-committees. Board members serve for a term of four years. This year, newly elected members will start in September 2024.

The current ISSDP Board consists of the President (Caitlin Hughes, AU); the Vice-President (Beau Kilmer, USA) and seven other members (Rebecca Askew, UK; John Collins, AT; Karen Joe Laidler, HK; Gideon Lasco, PH; Aileen O’Gorman, SCO/UK; Rosalie Liccardo Pacula, US; Liesbeth Vandam, PT). The Founding President, Peter Reuter, USA, is an ex-officio Board attendant while Lucy Strang (ISSDP Treasurer) is also a Board attendee.

Nominations and election process: The Board is elected from and by the membership. It is a rule of the Society’s by-laws that Board members must be drawn from at least four different countries. We wish particularly to encourage nominations from non-Anglo members/countries. Each member of the Board is considered to represent the country of their primary institutional affiliation, regardless of country of birth or citizenship.

Nominations should be supported by a proposer and seconder who should both be members of ISSDP. The proposer and seconder should ensure that the person nominated is a member and willing to serve. Self-nominations, with a proposer and seconder, are welcome also. The candidate, proposer and seconder should be copied into the nomination email to indicate their support. Nominations should attach a one-page statement with the details below. This will be circulated with the ballot paper.

• a short biography of the nominee;
• a note on the skills they would bring to the role of Board Member; and
• why they wish to stand/what they hope to accomplish as a member of the Board.

Nominations should be emailed to Aileen O’Gorman (Aileen.O’Gorman@uws.ac.uk) by Monday 22 July 2024.

After the closing date for nominations, a ballot paper listing all nominees will be circulated to the membership for electronic voting. Members may vote for as many candidates as there are seats open for election: this number will be confirmed when the ballot is circulated. Elections will be held in August 2024.

Please contact any of the nominations committee below if you have any questions.

Nominations Committee: Aileen O’Gorman (Chair); Judith Aldridge (judith.aldridge@manchester.ac.uk) and Nicola Singleton (nicolasingleton22@gmail.com).

ISSDP is attending the 67^th CND between 14-15 March and 18-22 March 2024. ISSDP President Caitlin Hughes took place in a High-Level Roundtable on 15 March 2024 on “The way forward: the road to 2029.” ISSDP is running a side-event on Wednesday 20 March from 8:00-8.50am on “Strengthening Drug Policy Evaluation.”

Download the event flyer

This side event will feature:

• Alex Stevens – University of Kent, UK
• Marie Jauffret Roustide – INSERM, France
• Rosario Queirolo – UCA – Uruguay
• Peter Reuter – University of Maryland, USA
• Katharina Kayser – Chief of UNODC Independent Evaluation Unit
• Caitlin Hughes – Flinders University / ISSDP President

When: 6 July 2023 at 10am Vienna.

This one-hour webinar will feature an overview of the 2023 World Drug Report (WDR) from Angela Me, Chief of the UNODC Research and Trend Analysis Branch, and a discussion with a panel of ISSDP experts about three of the latest WDR topics, including emerging issues in research and policy on psychedelics, regulating medical cannabis markets and drug policy and the environment.

Please register at: https://www.eventbrite.com.au/e/issdp-and-unodc-webinar-a-scientific-look-at-the-2023-world-drug-report-tickets-667284886057?aff=oddtdtcreator

The webinar will be recorded and available to all ISSDP members for anyone who cannot view it in real time.

Dear ICARA members and associated colleagues,

We are proud to be hosting a hybrid research workshop at the Kettil Bruun Society 2023 Conference on Tuesday 6th June from 15.00-16.30 GMT+1.

The aim of the workshop is to discuss Alcohol, Tobacco and other Drugs (ATOD) research capacity strengthening needs in LMIC countries, as well as developing potential research partnerships with researchers from these countries. We will build on the existing research capacity and expertise of workshop attendees, and the assets that we have, to discuss ways to address identified research capacity.

Attendees will be split into smaller groups by region and discussions will focus on the following areas:

• What areas of ATOD research have been done well in your country/region so far?
• What types of ATOD research are priorities in your country/region today?
• What are the main ATOD research areas where there is a gap now?
• What are the main challenges in undertaking ATOD research?
• What are your specific needs for undertaking this research both locally and internationally?
• How do you think ICARA could support those needs?
• What kinds of research partnerships would be interested in fostering with other LMIC researchers, if any?

Facilitators will make notes of all identified strengths, gaps and needs for each region and a whole-group discussion will take place where together we will start to group these needs according to commonalities (themes). The next steps for strengthening research capacity needs will then be agreed on by the whole group, and the potential role of ICARA in supporting these needs will be identified.

We invite researchers at different stages in their career who are from the Global South, to attend this free, hybrid workshop. If you are attending the KBS Conference in Johannesburg, you are welcome to attend in person. If you are not attending the conference, we invite you to attend online registering here via Eventbrite! Please disseminate to anyone in your network who might be interested.

We look forward to meeting you there (or online).

ISSDP will be taking part in the 66th United Nations Commission on Narcotics Drugs Meeting in Vienna from 13-17 March 2023. We are sending our first delegation as an ECOSOC registered organisation and sponsoring two key side events:

Other events at which ISSDP members are speaking are listed below:

Tuesday 14 March – 8:00-8:50am CEST

PRINCIPLE TO POLICY TO PRACTICE. IMPLEMENTING A HUMAN RIGHTS APPROACH WITH PEOPLE WHO USE DRUGS

Organized by the Release Legal Emergency and Drugs Service Limited with the support of Ghana, Norway, the Global Commission on Drug Policy and the International Centre on Human Rights and Drug Policy.

In person (M6) & online: https://bit.ly/3Jr7R6V

---

Tuesday 14 March – 8:00 -8:50am CET

URBAN DRUG POLICIES IN THE GLOBALISED WORLD: A LEXIMETRICAL FOCUS

Organized by the Nonviolent Radical Party, Transnational Transparty with the support of the European Coalition for Just and Effective Drug Policies.

Web-link: https://us06web.zoom.us/j/82200657239?pwd=Mk15SEJ0QjcxWFd4U01hVHUycy96UT09

---

Tuesday 14 March – 14:10-15:00 (CEST/Vienna)

UNDERSTANDING THE DRUG TRAFFICKING THREAT ALONG THE SOUTHERN ROUTE: SPECIAL FOCUS ON THE SOUTHERN AND EASTERN AFRICA REGION

Organised by the United Kingdom with the support of the UNODC, South Africa, Kenya, European Union, USA, Japan, GI-TOC.

Click here to join

---

Thursday, 16 March – 9.10-10.00 a.m.

MITIGATING THE RISKS OF CORPORATE CAPTURE FOR LEGAL CANNABIS MARKETS

Organized by the Transform Drug Policy Foundation with the support of the International Drug Policy Consortium, México Unido Contra la Delincuencia (MUCD), Health Poverty Action and the Norwegian Association for Safer Drug Policies.

In-person only (M0E07)

---

Thursday 16 March – 13:00-13:50 (CEST/Vienna)

THE FUTURE OF ILLICIT ECONOMIES IN AFGHANISTAN

Organised by the UNODC Division for Policy Analysis and Public Affairs, with the support of GI-TOC, London School of Economics and Political Science and University of Birmingham.

Click here to join

---

A link to other side events at CND66 is available here:
https://www.unodc.org/documents/commissions/CND_CCPCJ_joint/Side_Events/2023/2303166_Programme_CND_ebook.pdf

ISSDP 2023 will be hosted by RAND Europe in either Belgium or England either the last week of May or first week of June 2023.  Specifics on the conference will be coming soon.

General Membership Meeting, Tuesday November 22 in Lisbon Portugal at (online Zoom as well).  More to come.

ISSDP is launching a new excellence in research award that will recognise a piece of research published in the past 3 years that has made a substantial innovation in how we think about or conduct research in the area of drug policy, including (but not exclusively limited to) the methods and data used for conducting drug policy analysis, the theoretical models of or frameworks guiding work on the agents (consumers, suppliers, regulators) or systems (drug markets, health providers, criminal justice system, social services) that influence drug policy, and/or practical understanding of drug policy in the world today.

Award

The selected individual will receive a formal certificate from the society, a monetary award of $3000 US plus $500 in travel expenses, as well as the opportunity to give a 30-minute presentation at a dinner at the annual ISSDP meeting.

Nominations are due by September 30, 2022

Please click here for further information

Registration for the one-day ISSDP conference is Lisbon is now open.

To register for the conference, please go to  https://issdp.memberclicks.net/pre-lisbon-conference-registration

The SSA is now accepting abstracts for oral presentations (deadline: 3 July 2022) and poster presentations (deadline: 14 August 2022) for its Annual Conference on 3 and 4 November 2022.

More Information

To recognize a piece of research published in the past 3  years that has made a substantial innovation in how we think about or conduct research in the area of drug policy, including (but not exclusively limited to)  the methods and data used for conducting drug policy analysis, the theoretical models of or frameworks guiding work on the agents (consumers, suppliers, regulators) or systems (drug markets, health providers, criminal justice system, social services) that influence drug policy, and/or practical understanding of drug policy in the world today.

Award

The selected individual will receive a formal certificate from the society, a monetary award of $3000 US plus $500 in travel expenses, as well as the opportunity to give a 30-minute presentation at a dinner at the annual ISSDP meeting.

Eligibility criteria

• English-language publication (article, book, or report)
• Can be authored by an ISSDP member or a non-ISSDP member
• If the publication has multiple authors, they will have to choose one person to come to the meeting and accept the award
• Published since January 1 of ISSDP Conference year minus 3 years.
  • g., For 2022 ISSDP, eligibility date begins 1/1/19.
• Clock does not start until the research is officially published.
  • g., A paper first made available online in 2017 but not assigned volume/page numbers until 2018 would be eligible for 2021

Nominations

We will create a webform on the Memberclicks membership site where nominations can be submitted by anyone (including the author).

In addition to providing the citation, the nominator must provide a 200-500 word justification for why this piece of research has made a significant contribution to drug policy scholarship (e.g., an important finding that improves how we think about drug policy or drug policy analysis, creation or application of a novel methodology)

Timeline

For this first award, we will be accepting Nominations through June 2022.  Reviews of papers and discussion by the committee will take place by October.  The decision will be announced the first of November, and notified privately, but will not be publicly announced until the annual meeting.

Congratulations to former ISSDP President Professor Alison Ritter on election to the 2021 Fellows of the Academy of the Social Sciences in Australia – a wonderful and well deserved achievement.

More information: https://socialsciences.org.au/academy-fellow/?sId=0032u00000HpeAgAAJ

Satellite ISSDP conference at the Lisbon Addictions Meeting, Tuesday November 22. More details and call for abstracts coming in late November. Lisbon Addictions Conference Wed – Friday November 23-25.  ISSDP is co-producing the thematic track on Current and Future Challenges in Global Drug Policy.  Abstracts for this are currently open here:   Call for abstracts | Lisbon Addictions 2022

It is with great sadness that ISSDP reports the passing of our friend and colleague, Tomáš Zábranský MD, PhD. Tomáš was part of ISSDP during its origins, contributing both as a highly-regarded epidemiologist who studied blood-borne diseases and mortality among those who used drugs as well as someone who understood the importance of rigorous research reaching policy makers and the need for objective evaluation of government programs and spending. He was an early ISSDP Board member, serving the organization until 2014, sharing his knowledge and experience of how to build bridges between policy research and policy in practice. In 2014, he became the Advisor on Drug Policy to the Czech Prime Minister and later served as the Envoy of the Czech Minister of Health for the Implementation of Medical Cannabis into the Czech Medical System and for Illegal Drug Issues, thereby playing a key role in the development of the Czech drug policy. He also headed up the Czech National Monitoring Centre for Drugs and Drug Addiction (the national focal point). Tomáš never quit his academic scholarship, authoring over 100 publications in peer-reviewed journals in addition to several official reports. His smile, quick wit, and razor focused intellect will be sorely missed by all of us.

For more information on his life and contributions, please see the following:

https://www.remembr.com/tomas.zabransky

https://www.emcdda.europa.eu/news/2021/memoriam-tomas-zabransky_en

The ISSDP Board and 2021 Host committee have had to make the difficult decision to fully cancel the 2021 conference in Aguascalientes Mexico due to ongoing uncertainties and restrictions caused by COVID-19.

We are very disappointed that we will not be able to meet as a society in Mexico as originally planned, and hope that we will get another opportunity to meet there in coming years. Moreover, we have further decided that, due to the logistical difficulty of managing an engaging conference when dealing with all the world’s time zones, we will not shift the 2021 conference to a virtual setting. Instead, we  encourage you to participate in the ongoing ISSDP virtual seminar series that we have scheduled in an alternating time zones allowing members to join when it is convenient, and catch taped versions later when it is not convenient.

A complete list of our upcoming mentoring and research seminars can be found here: https://www.issdp.org/webinars.

‘How COVID has changed cannabis markets, use and policy’

Chair: Rosalie Liccardo Pacula.

Speakers: David Hammond, Judith Albridge and Bernd Werse.

Date:  June 17, 2021
Time: 17.00-19.00 SAST | 15.00-17.00 GMT | 16.00-18.00 BST/UK time

You will not be able to join the webinar without pre-registering.

Registration link:

https://zoom.us/webinar/register/WN_05_OvzfqQNaJMqnKMxx-Ig

The March 31st ISSDP Research Webinar was recorded and is available to our ISSDP members via the link below.

https://www.issdp.org/webinar-presentations/

ISSDP is launching a new ISSDP research webinar series that will run throughout 2021. Join us for the first webinar on 31 March to hear from Laura Atuesta from CIDE Mexico on “Organized crime-related disappearances in Mexico: Evidence from Durango, Tamaulipas and Coahuila.”

For details of this and future webinars see:
https://www.issdp.org/webinars/

On October 28th, Harm Reduction International will be launching a new report that draws on positive impacts of COVID on opioid substitution therapies from multiple countries. Be on the look out!

https://www.hri.global/

 

Key Findings from a Global Drug Survey survey that ran for 7 weeks from May – June 2020 are now available: 

https://www.globaldrugsurvey.com/gds-covid-19-special-edition-key-findings-report/

ISSDP has partnered with MemberClicks to create an administrative and communication system for its membership.

As ISSDP is growing and becoming increasingly global, Memberclicks can help us stay on top of membership, registration for events, communications and help us do a better job at facilitating more communication between our members.

Please be sure to update your portfolio by going here:

https://issdp.memberclicks.net/login#/login

A scientific look at the 2020 World Drug Report

A joint ISSDP-UNODC webinar took place on 2 July 2020.

The webinar featured an overview of the 2020 World Drug Report by Angela Me (Chief Research and Trend Analysis Branch, UNODC) and an ISSDP panel of experts discussing three key topics: 1) socioeconomic circumstances of heavy use, 2) access to controlled medicine and 3) the rise of meth and stimulants.

The Department of Criminology and Criminal Justice is very pleased to announce that our own Peter Reuter has just been named a Distinguished University Professor by the University of Maryland for his influential work on alternative drug policies in the United States and Western Europe. This is the highest honor bestowed on a tenured faculty member in recognition not just of excellence, but of impact and significant contributions to the nominee’s profession. Peter’s appointment follows closely on the appointment of Sally Simpson last year. CCJS has had an incredible track record in receiving DUP awards: Peter is the Department’s fifth faculty member to receive this award.

https://ccjs.umd.edu/feature/peter-reuter-named-umd-distinguished-university-professor

What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including demand, production, trafficking and availability (EMCDDA)

Dear Friends, Participants and Members,

We hope you and your families are safe and managing the global situation as best as you can.

The changing situation with respect to Coronavirus (COVID-19) coupled with its anticipated resurgence in late 2020 has led the ISSDP board to decide to cancel the 2020 ISSDP annual meeting altogether and instead to push back the currently planned meeting to next year.   Our host organization, CIDE in Mexico, has agreed to host the meeting for us next year, June 2-4 2021.  We have pushed the meeting back into early June in hopes that doing so will reduce the risk of us being impacted again next year.   We will be taking down the official host webpage for 2020 in light of this change, but please look for the launch of the new 2021 webpage shortly.   The host committee will be connecting with our currently accepted speakers and presenters to ascertain willingness to continue participation in the program next year and adjustments will be made.

We appreciate everyone’s patience with us, and advice, as we worked through the various scenarios and assessed the impacts of the various options.  Our hope is that by notifying you all of this change now, it may be possible to change travel arrangements without substantial losses.

Please stay safe and we hope to see many of you in Mexico in June 2021!

Warmest regards,

Rosalie Liccardo Pacula, President ISSDP

Caitlin Hughes, Vice-President ISSDP

Dear colleagues,

As you might be aware, several countries are implementing different measures to mitigate the transmission of the coronavirus (COVID-19). Such measures have included the cancellation or the postponement of international travels and events/meetings involving a large number of participants.

Even though in Mexico (update March 11th, 10 AM CST), there are only eight confirmed cases and none of these cases are in or near Aguascalientes, we have decided to postpone the event until further notice. We will communicate the new dates once we have a clearer picture of the evolution of the virus globally. This means that we will respect all payments made so far and we will extend early-bird registration once we have a new date.

We sincerely apologize for all the inconvenience this situation may carry. We will certainly try our best to solve any questions or concerns you may have with respect to the change of dates. If you need support contacting your hotel to change the reservation, you can send your reservation information to ISSDP2020@cide.edu and we will help you with the request.

Our solidarity with everyone affected by this situation.

Best regards,

The ISSDP Organizing Committee.

The call for articles for the special issue on ‘Killing in the name of the war on drugs in Asia’ is now announced at:

https://www.journals.elsevier.com/international-journal-of-drug-policy/call-for-papers/killing-in-the-name-of-the-war-on-drugs

Professor Alison Ritter, Director of the Drug Policy Modelling Program, UNSW and former ISSDP director  has been awarded an Officer of the Order of Australia (AO) for distinguished service to education, to drug and alcohol research and social policy, and to professional medical societies. A remarkable achievement.

Congratulations from all of ISSDP.

As many of you already know, our dear friend and colleague passed away this summer.  We will be having a special session at the 2020 ISSDP Annual meeting honouring Mark, his contributions to Drug Policy, and the legacy he has left.  If you are interested in participating, please contact Peter Reuter (preuter@umd.edu).

Information about funding opportunities related to drug policy that may be of interest to our membership.

1. The Justice Programme of the European Commission of the EU opened a call for transnational projects in the area of EU drug policy.
   https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/isfp-2019-ag-drugs
2. The Internal Security Fund-Police of the European Union  opened a call for projects aiming to improve law enforcement in the area of illicit drug trafficking.
   https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/isfp-2019-ag-drugs
3. COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks –  connects research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
   https://www.cost.eu/

Congratulations to Jack Spicer @jackhspicer for winning the best Early Career Researcher award at the 2019 ISSDP Conference in Paris for his work on “Between gang talk and prohibition: scapegoating and the transfer of responsibility for County Lines”